Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device

on behalf of the Copper 175mm IUD Phase 3 Clinical Investigator Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science